🔍

VIKASLIFE - Vikas Lifecare

📊 NSE: VIKASLIFE 🏢 Trading 📅 Last Updated: 12/14/2025 15:07

📢 Recent Corporate Announcements

Vikas Lifecare Publishes Financial Results for Q2 and Q3 FY2025-26 in Newspapers

🟡 NEUTRAL ⭐ 4/10

ROUTINE 📅 25 Apr 2026, 01:35 PM

Vikas Lifecare Limited has notified the stock exchanges regarding the newspaper publication of its un-audited financial results for multiple periods. The disclosure includes results for the quarter ended September 30, 2025, and the quarter and nine-month period ended December 31, 2025. These advertisements were published in Financial Express and Jansatta on April 24 and 25, 2026. This is a procedural compliance filing under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Published un-audited financial results for the quarter ended September 30, 2025.
Published un-audited financial results for the quarter and nine months ended December 31, 2025.
Advertisements released in Financial Express (English) and Jansatta (Hindi) on April 24 & 25, 2026.
Compliance maintained under Regulation 47 of SEBI (LODR) Regulations, 2015.

💡 Investors should review the detailed financial statements on the stock exchange websites to analyze the company's revenue and profit trends for the nine-month period. This specific announcement is a regulatory formality and does not contain new financial data beyond what was previously released.

Vikas Lifecare Reports Q2 FY26 Revenue of ₹140.98 Cr; Posts Net Loss of ₹3.49 Cr

🔴 NEGATIVE ⭐ 7/10

EARNINGS 📅 22 Apr 2026, 12:34 AM

Vikas Lifecare reported a standalone revenue of ₹140.98 crore for the quarter ended September 30, 2025, showing a modest 8% growth compared to ₹130.36 crore in the same period last year. However, the company posted a net loss of ₹3.49 crore for the quarter, a significant decline from a profit of ₹4.86 crore YoY, due to rising operational expenses and a lack of non-operating income. While the half-year (H1 FY26) net profit appears strong at ₹124.15 crore, this figure is heavily distorted by a massive one-time 'Other Income' of ₹132.75 crore recorded in the previous quarter. The board also approved seeking shareholder consent for related party transactions and investments.

Revenue from operations for Q2 FY26 stood at ₹140.98 crore, up 8% from ₹130.36 crore YoY.
Standalone net loss of ₹3.49 crore in Q2 FY26 compared to a net profit of ₹4.86 crore in Q2 FY25.
H1 FY26 profit of ₹124.15 crore is primarily driven by ₹132.75 crore in 'Other Income' from Q1.
Total assets grew to ₹805.24 crore as of September 30, 2025, from ₹692.92 crore in March 2025.
Board approved an addendum to the Postal Ballot for member consent regarding related party transactions and investments.

💡 Investors should exercise caution as the company's core operations were loss-making this quarter, with the annual profit figures heavily reliant on non-recurring other income. It is advisable to wait for clarity on the sustainability of operational margins and the nature of the fair value gains reported earlier in the year.

Vikas Lifecare Q2 Revenue Up 8% to ₹141 Cr; H1 Profit Boosted by ₹127 Cr Investment Gain

🔵 WATCH ⭐ 7/10

EARNINGS 📅 22 Apr 2026, 12:17 AM

Vikas Lifecare reported a standalone revenue of ₹140.98 crore for the quarter ended September 2025, an 8.1% increase year-on-year. Despite revenue growth, the company recorded a net loss of ₹3.49 crore for the quarter, compared to a profit of ₹4.86 crore in the same period last year. However, the half-year (H1) net profit surged to ₹124.15 crore, primarily driven by a massive non-cash remeasurement gain of ₹126.93 crore on investments. The board also approved seeking shareholder consent for expanded limits on related party transactions and investments.

Q2 FY26 revenue from operations increased to ₹140.98 crore from ₹130.36 crore YoY.
Reported a standalone net loss of ₹3.49 crore in Q2 FY26 versus a profit of ₹4.86 crore in Q2 FY25.
H1 FY26 net profit reached ₹124.15 crore, heavily influenced by ₹126.93 crore in fair value gains on investments.
Total assets grew to ₹805.24 crore as of September 30, 2025, compared to ₹692.92 crore in March 2025.
Board approved seeking member consent via Postal Ballot for related party transactions and investment limits.

💡 Investors should note that the significant H1 profit is due to non-operational investment revaluations rather than core business growth. It is advisable to monitor the company's operational margins and the impact of the proposed related party transactions on the balance sheet.

Vikas Lifecare to Issue 61.9 Crore Convertible Warrants via Preferential Basis

🟢 POSITIVE ⭐ 8/10

FUNDRAISE 📅 15 Apr 2026, 06:08 PM

Vikas Lifecare Limited has issued a postal ballot notice to seek shareholder approval for a significant fundraise through the issuance of up to 61,90,62,500 fully convertible warrants. These warrants will be offered on a preferential basis to both the Promoter/Promoter Group and Non-Promoter/Public categories. The company also plans to increase its Authorized Share Capital and amend its Articles of Association to facilitate this expansion of the capital base. Shareholders can cast their votes via e-voting from April 16, 2026, to May 15, 2026.

Proposed issuance of up to 61,90,62,500 fully convertible warrants on a preferential basis.
Warrants to be allocated to both Promoter/Promoter Group and Non-Promoter/Public Category members.
Proposal to increase the Authorized Share Capital and amend the Capital Clause of the Memorandum of Association.
Amendment of Articles of Association to include specific provisions for further capital issuance.
E-voting period for shareholder approval scheduled from April 16, 2026, to May 15, 2026.

💡 Investors should monitor the specific pricing of the warrants and the intended use of proceeds to gauge the potential for future growth versus equity dilution. The participation of promoters in the preferential issue is generally a positive signal of confidence in the company's prospects.

Vikas Lifecare to Raise Rs 99.05 Crore via Preferential Issue of 61.9 Crore Warrants

🟢 POSITIVE ⭐ 8/10

FUNDRAISE 📅 14 Apr 2026, 10:35 PM

Vikas Lifecare's Fund-Raising Committee has approved the allotment of 61.9 crore fully convertible warrants at an issue price of Rs 1.60 per warrant, totaling approximately Rs 99.05 crore. The issuance is split between promoters (33.5 crore warrants) and public investors (28.4 crore warrants). Notably, the promoter group's shareholding is projected to increase significantly from 14.22% to 24.20% upon full conversion of these warrants. The warrants are convertible into equity shares within 18 months, providing a clear path for capital infusion and increased promoter skin in the game.

Issuance of 61,90,62,500 fully convertible warrants at Rs 1.60 per warrant
Total aggregate fundraise amount of Rs 99.05 crore in this tranche
Promoter group stake to rise from 14.22% to 24.20% post-conversion
Warrants are convertible into equity shares (FV Re 1) within a maximum period of 18 months
Major promoter allottees include Just Right Life Limited (22.5 Cr warrants) and Advikca Finvest Limited (10 Cr warrants)

💡 The substantial increase in promoter stake is a positive signal of confidence in the company's future prospects. Investors should monitor the utilization of these funds and the impact of equity dilution once the warrants are converted.

Vikas Lifecare Receives Income Tax Demand Order of ₹22.99 Crore

🔴 NEGATIVE ⭐ 7/10

REGULATORY 📅 14 Apr 2026, 06:29 PM

Vikas Lifecare Limited has received assessment orders from the Income Tax Department raising a total tax demand of ₹22.99 Crore. The demand pertains to various assessment years and is based on certain additions and disallowances made by the tax authorities. The company received the formal communication on March 27, 2026, and is currently evaluating legal remedies to challenge the order. While management expects a favorable outcome at the appellate stage, the demand represents a significant potential financial liability.

Total income tax demand raised by the department amounts to ₹22.99 Crore.
The demand covers multiple assessment years and stems from assessment additions/disallowances.
Official receipt of the assessment orders occurred on March 27, 2026.
The company intends to file appeals against the orders within the prescribed timelines.
Management states there is no immediate material impact on current business operations.

💡 Investors should track the progress of the legal appeal as an adverse final ruling could significantly impact the company's liquidity. Maintain a cautious stance until further clarity is provided on the specific nature of the tax disallowances.

Vikas Lifecare Board Approves Fundraise of up to Rs. 200 Crores via Preferential Issue

🟢 POSITIVE ⭐ 8/10

FUNDRAISE 📅 11 Apr 2026, 12:39 PM

Vikas Lifecare's board has approved a significant capital infusion of up to Rs. 200 Crores to support its growth strategy and business plans for the current fiscal year. The funds will be raised through the issuance of equity shares or warrants on a preferential basis in one or more tranches. To facilitate this, the company is increasing its authorized share capital to Rs. 300 Crores and amending its Articles of Association. The final pricing and allottees will be determined by a newly authorized 'Fund Raising Committee' in compliance with SEBI norms.

Board approved fund raising not exceeding Rs. 200 Crores via preferential issue of shares or warrants.
Authorized Share Capital to be increased to Rs. 300 Crores consisting of shares with face value of Re. 1 each.
Proposed amendments to the Articles of Association (AOA) to include specific clauses for further issue of capital.
Funds are intended to support the company's business plan and growth strategy for the current fiscal year.
Shareholder approval will be sought via postal ballot for the proposed fundraise and capital increase.

💡 Investors should monitor the final issue price and the list of allottees to assess the quality of incoming capital and the extent of equity dilution. While the fundraise supports growth, the impact on earnings per share (EPS) will depend on how effectively the new capital is deployed.

Vikas Lifecare Board Approves Rs. 200 Crore Fundraise via Preferential Issue

🟢 POSITIVE ⭐ 8/10

FUNDRAISE 📅 11 Apr 2026, 12:32 PM

Vikas Lifecare's board has approved a significant fundraise of up to Rs. 200 Crores through the issuance of equity shares or warrants on a preferential basis. To accommodate this capital infusion, the company is increasing its Authorized Share Capital to Rs. 300 Crores. The funds are earmarked to support the company's business plan and growth strategy for the current fiscal year. Additionally, the company is amending its Articles of Association to streamline the process for further capital issuances.

Approved fundraising of up to Rs. 200 Crores via equity shares or warrants on a preferential basis.
Authorized Share Capital increased to Rs. 300 Crores, consisting of 300 crore shares of Re. 1 each.
Fund Raising Committee formed to finalize allottees and determine the issue price as per SEBI formula.
Articles of Association amended to include specific clauses for 'Further Issue of Capital'.
Company seeking shareholder approval for these proposals via postal ballot and e-voting.

💡 Investors should monitor the announcement of the specific allottees and the final issue price to gauge market interest. While the capital will fuel growth, existing shareholders should be aware of the impending equity dilution.

Vikas Lifecare to Close Trading Window from April 1, 2026, for FY26 Results

🟡 NEUTRAL ⭐ 3/10

ROUTINE 📅 31 Mar 2026, 01:07 PM

Vikas Lifecare Limited has announced the closure of its trading window effective April 1, 2026, in compliance with SEBI insider trading regulations. This closure is mandatory ahead of the declaration of the audited financial results for the quarter and financial year ending March 31, 2026. The restriction applies to promoters, directors, and designated persons to prevent any insider trading activities. The trading window will reopen 48 hours after the financial results are officially declared and made public.

Trading window closure starts from April 1, 2026, for all designated persons.
Closure is related to the audited financial results for the quarter and year ended March 31, 2026.
The window will remain closed until 48 hours after the results are announced.
Board meeting date for result approval will be intimated separately in due course.

💡 This is a routine regulatory filing with no direct impact on stock valuation. Investors should monitor for the upcoming board meeting date to assess the company's year-end financial performance.

Vikas Lifecare Extends Trading Window Closure Due to Delayed Q2, Q3, and FY26 Financial Results

🔴 NEGATIVE ⭐ 7/10

REGULATORY 📅 30 Mar 2026, 03:05 PM

Vikas Lifecare has announced a continued closure of its trading window as it has failed to finalize and disclose financial results for the quarters ended September 30, 2025, and December 31, 2025. The trading window, which has been closed since October 1, 2025, will now remain shut until 48 hours after the release of results for Q2, Q3, and the full year ending March 31, 2026. This prolonged delay in financial reporting is a significant regulatory concern and suggests internal administrative or accounting bottlenecks. The company has not yet fixed a date for the board meeting to approve these pending results.

Trading window remains closed since October 1, 2025, due to non-finalization of Q2 results
Closure now extended to cover pending results for Dec 31, 2025, and the full year ending March 31, 2026
Company has failed to meet standard SEBI timelines for reporting Q2 and Q3 FY2026 financials
Trading window will only reopen 48 hours after the eventual general availability of all pending results

💡 Investors should view the delay in financial reporting as a red flag regarding corporate governance and internal controls. It is advisable to wait for the audited results and management commentary before making new investment decisions.

Vikas Lifecare Reports Cyber-Attack; Website Taken Offline for Security Review

🔴 NEGATIVE ⭐ 4/10

OTHER 📅 07 Feb 2026, 05:29 PM

Vikas Lifecare Limited (VIKASLIFE) has informed the exchanges that its official website was subject to a cyber-attack involving unauthorized content and server hacking. The company has temporarily taken the website offline as a preventive measure to conduct a thorough technical and security review. Experts have been engaged to identify the breach source and implement security enhancements to prevent recurrence. While the core manufacturing and trading operations remain active, this incident highlights potential vulnerabilities in the company's digital infrastructure.

Official website and web server hacked, leading to unauthorized content display on Feb 7, 2026
Website proactively taken offline to ensure user safety and system integrity
Technical experts engaged to rectify the issue and implement preventive measures
Company's subsidiary, Genesis Gas Solutions, continues to hold a 20% share in the Indian gas metering market

💡 Investors should watch for updates on whether sensitive corporate or customer data was compromised. The immediate impact is reputational, but any disruption to business-critical systems would be a larger concern.

Vikas Lifecare Postpones Board Meeting for Q2 and Q3 FY26 Financial Results

🔵 WATCH ⭐ 4/10

BOARD_MEETING 📅 07 Feb 2026, 05:27 PM

Vikas Lifecare Limited has announced the postponement of its Board Meeting originally scheduled for February 07, 2026, citing technical reasons. The meeting was intended to consider and approve the Unaudited Financial Results for both the quarter ended September 30, 2025, and the quarter ended December 31, 2025. The company expects to hold the rescheduled meeting next week, with a specific date to be announced separately. This delay leaves investors waiting for performance data covering the last two consecutive quarters.

Board meeting scheduled for February 07, 2026, postponed due to technical reasons.
Approval of financial results for the quarter and half-year ended September 30, 2025, is delayed.
Approval of financial results for the quarter and nine months ended December 31, 2025, is also delayed.
The company plans to reschedule the meeting for the following week.
The brief meeting on Feb 7 concluded within 45 minutes without approving the financials.

💡 Investors should monitor for the new meeting date announcement to review the pending financial results. Exercise caution as the delay in reporting two consecutive quarters of data can sometimes indicate administrative or accounting bottlenecks.

Vikas Lifecare Postpones Board Meeting for Q2 and Q3 FY26 Financial Results

🔵 WATCH ⭐ 6/10

BOARD_MEETING 📅 07 Feb 2026, 05:26 PM

Vikas Lifecare Limited has announced the postponement of its Board Meeting originally scheduled for February 7, 2026, due to technical reasons. The meeting was intended to consider and approve the unaudited financial results for two periods: the quarter and half-year ended September 30, 2025, and the quarter and nine months ended December 31, 2025. The company expects to hold the rescheduled meeting next week. This delay indicates a backlog in financial reporting as results for two consecutive quarters are pending approval.

Board meeting on February 7, 2026, postponed citing technical reasons.
Agenda included approval of financial results for the quarter ended September 30, 2025.
Agenda also included approval of financial results for the quarter ended December 31, 2025.
The rescheduled meeting is proposed to be held in the following week.
The company will separately intimate the new date for the board meeting.

💡 Investors should monitor the announcement of the new meeting date and closely examine the upcoming results for any fundamental issues causing the reporting delay. Exercise caution as the company is currently behind on its regulatory filing timeline for the September 2025 quarter.

Vikas Lifecare Takes Website Offline for Security Review After Technical Anomaly

🔵 WATCH ⭐ 4/10

OTHER 📅 20 Jan 2026, 06:49 PM

Vikas Lifecare Limited has temporarily suspended its official website operations following the detection of unauthorized content and technical anomalies on January 20, 2026. The company has proactively engaged security experts to conduct a comprehensive review and implement preventive measures to ensure system integrity. While this is an operational disruption, the company's core business in polymer manufacturing and its 20% market share in gas metering through subsidiary Genesis Gas Solutions remain the primary value drivers. Investors should monitor for the restoration of digital services and any further disclosures regarding data integrity.

Official website taken offline on January 20, 2026, due to unauthorized content detection.
Technical and security review initiated with external experts to identify and rectify the issue.
Subsidiary Genesis Gas Solutions commands approximately 20% share in the Indian domestic gas metering market.
Core manufacturing operations in polymers and rubber compounds are unaffected by the digital outage.

💡 Investors should treat this as a minor operational risk and monitor for the timely restoration of the website. Focus remains on the company's business diversification and its joint venture with IGL for gas meter manufacturing.

Vikas Lifecare Submits SEBI Regulation 74(5) Compliance Certificate for Q3 FY26

🟡 NEUTRAL ⭐ 2/10

ROUTINE 📅 15 Jan 2026, 05:24 PM

Vikas Lifecare Limited has filed its quarterly compliance certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018. The document confirms that the company has processed all requests for the dematerialization and rematerialization of securities for the quarter ended December 31, 2025. This is a standard procedural filing required by all listed companies in India to ensure the integrity of the shareholding records. The filing indicates that the company is maintaining its regulatory obligations with the depositories and stock exchanges.

Compliance certificate submitted for the quarter ended December 31, 2025
Adherence to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018
Confirms processing of dematerialization and rematerialization requests during the period
Information has been furnished to both NSE and BSE where the company is listed

💡 This is a routine regulatory update with no impact on the company's fundamentals or stock price. No action is required from investors.

View All VIKASLIFE Announcements on Live Market Tracking →

💰 Financial Performance

Revenue Growth by Segment

The Agro Products Division is targeting 80% growth, aiming for INR 360 Cr in the current fiscal year compared to INR 200 Cr in the previous fiscal. The division achieved INR 48 Cr in sales before bagging a fresh order of INR 15.5 Cr in Q2 2023-24.

Geographic Revenue Split

Not disclosed in available documents; however, the company operates factories in Rajasthan (Shahjahanpur) and Karnataka (Mangaluru) and is headquartered in Delhi.

Profitability Margins

For 9MFY22, the company reported a net profit of INR 5.7 Cr on revenues of INR 211 Cr, representing a net profit margin of approximately 2.7%. Profitability is expected to improve as the company shifts from B2B trading to higher-margin B2C segments like FMCG and textiles.

EBITDA Margin

Not explicitly disclosed in percentage terms, but the company reported a net profit of INR 5.7 Cr for 9MFY22. Profitability metrics are a key rating sensitivity for upward revision.

Capital Expenditure

The company's subsidiary, Genesis Gas Solutions, entered a JV with Indraprastha Gas Limited (IGL) to set up a smart meter manufacturing plant with a planned capital expenditure of INR 110 Cr.

Credit Rating & Borrowing

Infomerics reaffirmed a long-term rating of IVR BB+/Stable and a short-term rating of IVR A4+. The company has an overall gearing ratio of 0.62x as of March 31, 2021, down from 0.75x in 2020.

⚙️ Operational Drivers

Raw Materials

Key raw materials include polymers and rubber compounds such as EVA, PVC, PP, and PE, which are used for manufacturing specialty additives and up-cycled compounds.

Import Sources

Not disclosed in available documents; however, the company is exposed to foreign exchange fluctuations, suggesting international sourcing for certain polymer products.

Key Suppliers

The company is a Del-Credere agent for ONGC (Oil and Natural Gas Corporation Ltd) - Petro Additions Limited, which ensures a steady supply of petrochemical products.

Capacity Expansion

The cashew processing facility in Mangaluru has an installed capacity of 1,000 tonnes/day. The company has acquired 36.41 acres of land since June 2021 and targets 100-150 acres of cultivable land by March 2024.

Raw Material Costs

Not disclosed as a specific percentage of revenue, but the company is exposed to price volatility in the petrochemical and agro-commodity markets.

Manufacturing Efficiency

Average working capital utilization for the 12 months ending January 2022 stood at approximately 50%, reflecting adequate cushion for incremental requirements.

📈 Strategic Growth

Expected Growth Rate

80%

Growth Strategy

Growth will be driven by diversifying into B2C segments including FMCG and Textiles (via the INR 12.5 Cr acquisition of MSR Apparels), expanding the Agro Products division through backward integration and land acquisition (targeting 150 acres), and a high-tech JV with IGL for smart meter manufacturing (INR 110 Cr Capex).

Products & Services

Polymer and rubber compounds, specialty additives for plastics, up-cycled compounds, cashews, agro products (rice, pulses), smart gas meters, and textile garments.

Brand Portfolio

Genesis Gas Solutions, MSR Apparels.

New Products/Services

Smart Gas Meters (via Genesis JV) and Textile garments (via MSR Apparels acquisition).

Market Expansion

The company is eyeing export orders for its Agro Products business and is establishing rice processing facilities to elevate its presence in international markets by 2024-25.

Strategic Alliances

Joint Venture with Indraprastha Gas Limited (IGL) for smart meter manufacturing and empanelment with NAFED for agro-product expansion.

🌍 External Factors

Industry Trends

The industry is shifting toward smart infrastructure (Smart Gas Meters) and government-mandated digital adoption. The agro-industry is growing at a steady pace, while the polymer industry is seeing a shift toward up-cycled and environmentally friendly compounds.

Competitive Landscape

The company operates in a highly competitive industry with significant players in the petrochemical trading and agro-commodity sectors.

Competitive Moat

The company's moat is built on its Del-Credere agency status with ONGC and its empanelment with NAFED, providing a competitive edge in sourcing and distribution that is difficult for smaller competitors to replicate.

Macro Economic Sensitivity

Highly sensitive to agro-climatic conditions and GDP growth, which affects demand for infrastructure and consumer products.

Consumer Behavior

Increasing consumer demand for FMCG and essential products has prompted the company's foray into the B2C segment.

Geopolitical Risks

Exposure to foreign exchange fluctuations suggests vulnerability to international trade tensions and currency volatility.

⚖️ Regulatory & Governance

Industry Regulations

Operations are governed by ISO 9001:2015 standards and pollution norms related to polymer manufacturing and plastic waste management.

Environmental Compliance

The company fulfills mandated EPR (Extended Producer Responsibility) obligations by manufacturing up-cycled compounds from plastic waste.

Legal Contingencies

As of November 14, 2025, the company reported a delay in quarterly results due to the need for verification of certain transactions and valuations within subsidiaries; specific case values were not disclosed.

⚠️ Risk Analysis

Key Uncertainties

The primary uncertainty involves the verification of transactions and valuations within subsidiaries, which delayed the Q2 FY26 financial results. Agro-climatic risks also pose a threat to the 80% growth target in the agro segment.